Loading...
OTCM
ALMDF
Market cap8mUSD
, Last price  
USD
Name

Allmed Solutions Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
-72.62%
Rev. gr., 5y
16.57%
Revenues
0k
2,563,0002,669,0004,701,0004,916,0005,178,0007,353,0007,703,0009,279,00011,147,0009,719,0005,545,00000
Net income
1m
P
-14,067,000-29,787,000-50,005,000-24,644,000-20,932,000-23,917,000-22,679,000-20,175,00021,988,000-10,893,0001,457,000-11,193,0001,422,000
CFO
-8m
L
-13,097,000-29,374,000-13,407,000-19,026,000-15,874,000-17,271,000-18,417,000-16,024,000-12,329,000-8,817,000-5,477,000-10,215,0007,136,000-8,025,000

Profile

Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.
URL
https://www.allium-medical.com/
IPO date
Feb 01, 2007
Employees
19
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
12,072
2,918
Unusual Expense (Income)
NOPBT
(12,072)
(2,918)
NOPBT Margin
Operating Taxes
(947)
Tax Rate
NOPAT
(12,072)
(1,971)
Net income
1,422
-112.70%
(11,193)
-868.22%
Dividends
Dividend yield
Proceeds from repurchase of equity
(5,494)
12,387
BB yield
-56,628.48%
Debt
Debt current
384
334
195
Long-term debt
854
1,416
1,141
Deferred revenue
Other long-term liabilities
148
Net debt
(41,939)
(55,351)
(26,395)
Cash flow
Cash from operating activities
(8,025)
7,136
(10,215)
CAPEX
(118)
(119)
(438)
Cash from investing activities
11,078
(21,597)
2,184
Cash from financing activities
(5,799)
(288)
12,015
FCF
286
(11,436)
(3,416)
Balance
Cash
43,177
57,101
21,032
Long term investments
6,699
Excess cash
43,177
57,101
27,731
Stockholders' equity
(214,162)
(203,092)
(204,686)
Invested Capital
256,800
259,941
259,463
ROIC
ROCE
EV
Common stock shares outstanding
112
88
Price
0.34
-8.60%
0.37
49.40%
0.25
-43.15%
Market cap
42
90.20%
22
-99.94%
EV
(52,758)
(23,932)
EBITDA
558
(11,596)
(2,368)
EV/EBITDA
4.55
10.11
Interest
46
Interest/NOPBT